Gerrit Franciscus Landolt
Keine laufenden Positionen mehr
Profil
Gerrit Franciscus Landolt worked as a Director of Intellectual Property & Legal at deVGen NV from 2000 to 2004.
He then worked as a Vice President of Intellectual Property & Legal at Ablynx NV from 2004 to 2018.
Landolt received his undergraduate and graduate degrees from the University of Leiden and a graduate degree from the University of Antwerp.
Ehemalige bekannte Positionen von Gerrit Franciscus Landolt
| Unternehmen | Position | Ende |
|---|---|---|
| ABLYNX | General Counsel | 01.01.2018 |
deVGen NV
 deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | General Counsel | 01.01.2004 |
Ausbildung von Gerrit Franciscus Landolt
| University of Leiden | Graduate Degree |
| University of Antwerp | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
deVGen NV
deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | Health Technology |
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
